Home/Filings/4/0001562180-24-006440
4//SEC Filing

DICICCO WENDY F 4

Accession 0001562180-24-006440

CIK 0001314102other

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 4:32 PM ET

Size

5.4 KB

Accession

0001562180-24-006440

Insider Transaction Report

Form 4
Period: 2024-08-20
Transactions
  • Purchase

    Common Stock

    2024-08-20$7.79/sh+2,567$19,9979,967 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.77 to $7.81. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother

Related Parties

1
  • filerCIK 0001225165

Filing Metadata

Form type
4
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 4:32 PM ET
Size
5.4 KB